Abdullah Amer Al Nahdi

Abdullah Amer Al Nahdi is the founder of Nahdi Medical Co., which was founded in 1986. Al Nahdi started the company by purchasing two pharmacies in Jeddah in 1986, a year after he graduated from university. He obtained his undergraduate degree from King Abdulaziz University. The company has more than 1,222 pharmacies, mostly in Saudi Arabia and some in the UAE.

Nahdi Medical Company has appointed Abdullah Al Nahdi as chairman of its board of directors, placing the company's founder at the head of the board for a new term. The board took the decision at its first meeting of the term on the seventh of October and the company disclosed it to the Saudi Exchange the following day. He served as vice chairman of the board before this appointment, and is also founder and chairman of the Al Nahdi Family Office, established in 2019.

Al Nahdi currently holds multiple business leadership positions, including Chairman of Al-Nahdi Transport Co., the Director of King Salman Center For Disability Research, and the General Director of Nahdi Transportation Co. Nahdi Medical, which recorded $2.7 billion in revenue in 2025, went public on the Saudi Exchange in 2022.

Career history

• Chairman of the Board of Directors at Nahdi Medical Company (October 2026–present)
• Vice Chairman of Nahdi Medical Company (2021–October 2026)
• Founder of Nahdi Medical Co. (1986)
• Chairman of Al-Nahdi Transport Co.
• Director of King Salman Center For Disability Research

What Abdullah Amer Al Nahdi could bring to the chairmanship: With four decades of entrepreneurial experience building Nahdi Medical from two pharmacies into a publicly-listed healthcare giant with over 1,200 locations, Al Nahdi brings deep operational expertise in retail pharmacy expansion, market consolidation, and strategic growth. His establishment of a family office signals sophisticated wealth management and succession planning capabilities. His roles spanning healthcare, transportation, and disability research indicate a diversified business acumen and community commitment that could position the company for digital healthcare innovation and regional expansion beyond its core pharmacy operations.